Gisela Riu
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Half-dose glucarpidase: an effective rescue for toxic methotrexate plasma concentrations in a patient with bilateral primary vitreoretinal lymphoma.
Journal: Annals of hematology
Published: December 02, 2025
Avatrombopag for post-transplant thrombocytopenia following allogeneic haematopoietic stem cell transplantation: A single-centre retrospective study.
Journal: British journal of haematology
Published: October 01, 2025
Validation of the CARE-BMT Score and Proposal of a Modified Risk Model With Post-Transplant Cyclofosfamide for Predicting Early Cardiac Events After Allo-HCT.
Journal: Transplantation and cellular therapy
Published: July 09, 2025
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study.
Journal: Experimental hematology & oncology
Published: December 26, 2024
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation.
Journal: Bone marrow transplantation
Published: April 19, 2024
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
Journal: The oncologist
Published: December 09, 2023
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study.
Journal: Annals of hematology
Published: July 18, 2023
Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 30, 2022
Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: October 12, 2022
Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis.
Journal: JCO precision oncology
Published: December 01, 2019
Oral levetiracetam for prevention of busulfan-induced seizures in adult hematopoietic cell transplant.
Journal: International journal of clinical pharmacy
Published: June 17, 2019
Last Updated: 09/26/2026